Axsome Therapeutics, Inc.AXSMNASDAQ
Loading
Interest Expense Over TimeStrong
Percentile Rank83
3Y CAGR-3.7%
5Y CAGR+20.6%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
-3.7%/yr
vs +59.7%/yr prior
5Y CAGR
+20.6%/yr
Recent deceleration
Acceleration
-63.4pp
Decelerating
Percentile
P83
Within normal range
vs 5Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$6.56M-0.2%
2024$6.57M+1.8%
2023$6.45M-12.0%
2022$7.33M+28.8%
2021$5.70M+122.0%
2020$2.57M+107.0%
2019$1.24M+10.0%
2018$1.13M-15.9%
2017$1.34M+912.1%
2016$132424.00-